Renal cell carcinoma (RCC) has the highest mortality rate of all genitourinary cancers, and
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …

Introduction Multi-drug resistance (MDR) is a hindrance toward the successful treatment of
cancers. The primary mechanism that gives rise to acquired chemoresistance is the …

Clear cell renal cell carcinoma (ccRCC) is a common kidney malignancy characterized by a
poor prognosis. Suppressor of variegation 3–9 homolog 1 (SUV39H1), which encodes a …

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer and is
associated with poor prognosis. The histone H3 lysine 36 methyltransferase SET-domain …

Ferroptosis is a newly described regulated form of cell death that contributes to the
progression of non-small cell lung cancers (NSCLCs). MicroRNA-302a-3p (miR-302a-3p) …

Long-noncoding RNAs (lncRNAs) have been shown to participate in sensitizing or de-
sensitizing cancer cells to chemical drugs during cancer therapeutics. Notably, a plethora of …

Renal cell carcinoma (RCC) includes 2.2% of all diagnosed cancers and 1.8% of cancer-
related mortalities. The available biomarkers or screening methods for RCC suffer from lack …

Background The development of drug resistance and high mortality rates are the major
problems observed in non-small cell lung cancer (NSCLC). Biomarkers indicating and …

Long non-coding (lncRNA) lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-
AS1) has been validated to be implicated in manifold cancers, whereas its function in glioma …

Over the course of more than 500 million years, the kidneys have undergone a remarkable
evolution from primitive nephric tubes to intricate filtration-reabsorption systems that …